Krismeikesari Krismeikesari. “Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis”. Open Access Indonesian Journal of Medical Reviews 5, no. 6 (November 12, 2025): 1772-1789. Accessed February 4, 2026. https://www.hmpublisher.com/index.php/OAIJMR/article/view/818.